drug reps are suggesting that Actonel (risedronate) causes fewer GI side effects than Fosamax (alendronate)

August 2003

Some drug reps are suggesting that Actonel (risedronate) causes fewer GI side effects than Fosamax (alendronate).

It's true that some comparisons show a potential advantage to Actonel. But there are also studies showing no difference.

Most of the research is company-sponsored. It's no surprise that results tend to favor the sponsoring company's drug.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote